20 results · 28ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

BIOPOTENTIAL SURFACE ELECTRODE

FDA 510(k)
FDA Class 2 ·Neurology

Barricade Coil System

FDA UDI
BALT USA LLC·00818053020605·Barricade Coil System (BCS) is intended for the...

SAFIRA

FDA UDI
MEDOVATE LIMITED·05060727270068·SAFIRA System hand operator for controlling SAF...

Master Series

FDA UDI
AMERICAN ORTHODONTICS CORPORATION·00190746099410·DB BRACKET MASTER SERIES MAND LEFT 2ND BICUSPID...

CONLIN MOLAR BANDS

FDA UDI
Ortho Arch Company Inc·D9099000591·MOLAR BAND CONLIN RX LOWER LEFT 43

XBraid TT

FDA UDI
RIVERPOINT MEDICAL, LLC·00810020084979·Suture Tape

POWDER FREE VINYL PATIENT EXAMINATION GLOVES, COLORED (WHITE)

FDA 510(k)
FDA Class 1 ·General Hospital

IMAGO C21 DIAGNOSTIC ULTRASOUND SYSTEM

FDA 510(k)
FDA Class 2 ·Radiology

CUP: MPACT DOUBLE MOBILITY ACETABULAR SHELL 48

FDA Adverse Event
Injury ·MEDACTA INTERNATIONAL SA·Product code LPH·August 3, 2020

Contrast Media, Ultrasound

FDA Pre-Market Approval
FDA Class 3 ·ALBUNEX(R) ALBUMIN (HUMAN) 5%, SONICATED

Contrast Media, Ultrasound

FDA Pre-Market Approval
FDA Class 3 ·ALBUNEX(R) ECHOCARDIOGRAPHY CONTRAST MICROSPHERES

Contrast Media, Ultrasound

FDA Pre-Market Approval
FDA Class 3 ·ALBUNEX(R) ECHOCARDIOGRAPHY CONTRAST MICROSPHERES

Contrast Media, Ultrasound

FDA Pre-Market Approval
FDA Class 3 ·ALBUNEX(R) ECHOCARDIOGRAPHY CONTRAST MICROSPHERES

TT AUGMENTED 360 BASEPLATE #S-R 15°

FDA Adverse Event
Injury ·LIMACORPORATE S.P.A.·Product code PHX·January 3, 2024

MASUNAGA since 1905

FDA UDI
MASUNAGA OPTICAL MFG.CO.,LTD.·04582644465040·

PINNACLE MTL INS NEUT36IDX56OD

FDA Adverse Event
Injury ·DEPUY ORTHOPAEDICS INC US·Product code KWA·June 27, 2014

LIGASURE ATLAS HANDSWITCHING 37CM

FDA Adverse Event
Malfunction ·COVIDIEN LLC (SHANGHAI)·Product code GEI·November 9, 2010

M SERIES

FDA Adverse Event
Malfunction ·ZOLL MEDICAL CORP·Product code MKJ·December 26, 2012

Vereos PET/CT, Model No. 882446 Product Usage: Positron Emission Tomography (PET) and X-ray Computed Tomography (CT) systems. The CT subsystem images anatomical cross-sections by computer reconstruction of X-ray transmission data. The PET subsystem images the distribution of PET anatomy-specific radiopharmaceuticals in the patient. The PET/CT system is used for the purposes of detecting, localizing, diagnosing, staging, re-staging, and follow-up for monitoring therapy response of various diseases in oncology, cardiology, and neurology. The system is intended to image the whole body, heart, brain, lung, gastrointestinal, bone, lymphatic, and other major organs for a wide range of patient types, sizes, and extent of diseases. Both subsystems can also be operated as fully functional, independent diagnostic tools, including application of the CT scanner for diagnosis and for use in radiation therapy planning.

FDA Enforcement
Class II ·Terminated·Philips Medical Systems (Cleveland) Inc·July 10, 2019

Vereos PET/CT, Software version 2.0.1. Model Number: 882446 Product Usage: The Philips Vereos PET/CT system is a diagnostic imaging device that combines Positron Emission Tomography (PET) and X-ray Computed Tomography (CT) systems. The CT subsystem images anatomical cross-sections by computer reconstruction of X-ray transmission data. The PET subsystem images the distribution of PET anatomy-specific radiopharmaceuticals in the patient. The PET/CT system is used for the purposes of detecting, localizing, diagnosing, staging, re-staging, and follow-up for monitoring therapy response of various diseases in oncology, cardiology, and neurology. The system is intended to image the whole body, heart, brain, lung, gastrointestinal, bone, lymphatic, and other major organs for a wide range of patient types, sizes, and extent of diseases. Both subsystems can also be operated as fully functional, independent diagnostic tools, including application of the CT scanner for diagnosis and for use in radiation therapy planning.

FDA Enforcement
Class II ·Terminated·Philips Medical Systems (Cleveland) Inc·November 7, 2018